Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
1988 • 17,059 citations
p53 Mutations in Human Cancers
1991 • 8,133 citations
The p53 tumour suppressor gene
1991 • 3,871 citations
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
1989 • 3,557 citations
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 • 2,081 citations
The p53 proto-oncogene can act as a suppressor of transformation
1989 • 2,019 citations
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 • 1,796 citations
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
1990 • 1,080 citations
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
1990 • 978 citations
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
1990 • 801 citations
p53 functions as a cell cycle control protein in osteosarcomas.
1990 • 774 citations
Wild-type p53 can inhibit oncogene-mediated focus formation.
1989 • 738 citations
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
1991 • 544 citations
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
1990 • 540 citations
Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression
1986 • 508 citations
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
1990 • 502 citations
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
1981 • 491 citations
Methods in clinical chemistry
1987 • 464 citations
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
1990 • 409 citations
Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
1990 • 353 citations
Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli
1992 • 335 citations
Nuclear Accumulation of p53 Protein Is Mediated by Several Nuclear Localization Signals and Plays a Role in Tumorigenesis
1990 • 328 citations
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.
1983 • 313 citations
Genetic basis for p53 overexpression in human breast cancer.
1991 • 287 citations
p53 Functions as a Cell Cycle Control Protein in Osteosarcomas
1990 • 224 citations
Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significance
1989 • 197 citations
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
1991 • 192 citations
Nuclear localization is essential for the activity of p53 protein.
1991 • 190 citations
Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport
1991 • 180 citations
Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells
1981 • 177 citations
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
1990 • 165 citations
p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
1990 • 156 citations
Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy.
1986 • 146 citations
Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein.
1991 • 142 citations
Proteins controlling the nuclear uptake of NF-κB, Rel and dorsal
1991 • 105 citations
Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53
1983 • 104 citations
Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
1991 • 92 citations
Involvement of wild-type p53 protein in the cell cycle requires nuclear localization.
1991 • 53 citations
Induction of Growth Arrest by a Temperature-Sensitive p53 Mutant Is Correlated with Increased Nuclear Localization and Decreased Stability of the Protein
1991 • 35 citations